BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38872849)

  • 1. Second Time's the Charm? Assessing the Sensitivity and Yield of Inpatient Diagnostic Algorithms for Pulmonary Tuberculosis in a Low-Prevalence Setting.
    Dugdale CM; Zachary KC; McEvoy DS; Branda JA; Courtney A; Craig R; Doms A; Germaine L; Green CV; Gulbas E; Hooper DC; Hurtado RM; Hyle EP; Jerry MS; Lazarus JE; Paras M; Turbett SE; Shenoy ES
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae253. PubMed ID: 38872849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
    Luetkemeyer AF; Firnhaber C; Kendall MA; Wu X; Mazurek GH; Benator DA; Arduino R; Fernandez M; Guy E; Johnson P; Metchock B; Sattler F; Telzak E; Wang YF; Weiner M; Swindells S; Sanne IM; Havlir DV; Grinsztejn B; Alland D;
    Clin Infect Dis; 2016 May; 62(9):1081-8. PubMed ID: 26839383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting.
    Peng J; Song J; Wang F; Zuo P; Lu Y; Liu W; Tian L; Chen Z; Zhu Y; Wang X; Shen N; Wang X; Wu S; Yu Q; Vallance BA; Jacobson K; Sun Z; Yu HB
    Front Cell Infect Microbiol; 2021; 11():650163. PubMed ID: 33816355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea.
    Chang J; Sung H; Jo KW; Shim TS; Kim MN
    Jpn J Infect Dis; 2021 Nov; 74(6):537-542. PubMed ID: 33790071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of direct and concentrated acid-fast smears to identify specimens culture positive for Mycobacterium spp.
    Peterson EM; Nakasone A; Platon-DeLeon JM; Jang Y; de La Maza LM; Desmond E
    J Clin Microbiol; 1999 Nov; 37(11):3564-8. PubMed ID: 10523552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of a nucleic acid amplification test in the diagnosis of pulmonary tuberculosis at an urban hospital with a high prevalence of TB/HIV.
    Adelman MW; Kurbatova E; Wang YF; Leonard MK; White N; McFarland DA; Blumberg HM
    PLoS One; 2014; 9(7):e100649. PubMed ID: 25014783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a Single Xpert MTB/RIF Assay to Determine the Duration of Airborne Isolation in Hospitalized Patients With Suspected Pulmonary Tuberculosis.
    Poonawala H; Leekha S; Medina-Moreno S; Filippell M; Johnson JK; Redfield RR; Saharia KK
    Infect Control Hosp Epidemiol; 2018 May; 39(5):590-595. PubMed ID: 29582718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmatic Impact of Implementing GeneXpert MTB/ RIF Assay for the Detection of
    Shrestha P; Khanal H; Dahal P; Dongol P
    Open Microbiol J; 2018; 12():9-17. PubMed ID: 29541267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
    Ozkutuk N; Surucüoglu S
    Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing nosocomial transmission of pulmonary tuberculosis: when may isolation be discontinued for patients with suspected tuberculosis?
    Siddiqui AH; Perl TM; Conlon M; Donegan N; Roghmann MC
    Infect Control Hosp Epidemiol; 2002 Mar; 23(3):141-4. PubMed ID: 11918119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting.
    Opota O; Zakham F; Mazza-Stalder J; Nicod L; Greub G; Jaton K
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30541937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Xpert MTB/RIF with AFB smear and AFB culture in suspected cases of paediatric tuberculosis in a tertiary care hospital, Karachi.
    Qureshi S; Sohaila A; Hannan S; Amir Sheikh MD; Qamar FN
    J Pak Med Assoc; 2019 Sep; 69(9):1273-1278. PubMed ID: 31511711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision making to discharge patients from airborne infection isolation rooms: The role of a single GeneXpert MTB/RIF strategy in Brazil.
    Menon LJB; Feliciano CS; de Campos MR; Bollela VR
    Infect Control Hosp Epidemiol; 2020 Jul; 41(7):784-788. PubMed ID: 32299529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens.
    Lama C; Adhikari S; Sapkota S; Regmi RS; Ghimire GR; Banjara MR; Ghimire P; Rijal KR
    Diseases; 2022 Oct; 10(4):. PubMed ID: 36278581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Accuracy of Xpert MTB/RIF in Sputum Smear-Negative Pulmonary Tuberculosis.
    Rasheed W; Rao NA; Adel H; Baig MS; Adil SO
    Cureus; 2019 Aug; 11(8):e5391. PubMed ID: 31620317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of
    Bourgi K; Patel J; Samuel L; Kieca A; Johnson L; Alangaden G
    Open Forum Infect Dis; 2017; 4(2):ofx045. PubMed ID: 28470022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia.
    Karuniawati A; Burhan E; Koendhori EB; Sari D; Haryanto B; Nuryastuti T; Gayatri AAAY; Bahrun U; Kusumawati RL; Sugiyono RI; Susanto NH; Diana A; Kosasih H; Naysilla AM; Lokida D; Neal A; Siddiqui S; Lau CY; Karyana M
    Front Med (Lausanne); 2022; 9():909198. PubMed ID: 36743681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.